CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-07 | Pierce Christopher EVP and Chief of Business Oper | Exercise or conversion · Employee Stock Option (right to buy) | −828 | 7,818 | ||
| 2021-04-07 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion | +1,000 | $1.89 | $2K | 1,444 |
| 2021-04-07 | Morosini Deborah EVP, Chief of Clinical Affairs | Sale | −1,000 | $40.04 | $40K | 444 |
| 2021-04-07 | Morosini Deborah EVP, Chief of Clinical Affairs | Exercise or conversion · Employee Stock Option (right to buy) | −1,000 | 7,646 | ||
| 2021-04-07 | Mauro David J Chief Medical Officer | Exercise or conversion | +15,383 | $1.89 | $29K | 15,383 |
| 2021-04-07 | Mauro David J Chief Medical Officer | Sale | −8,300 | $39.03 | $324K | 7,083 |
| 2021-04-07 | Mauro David J Chief Medical Officer | Sale | −7,083 | $39.69 | $281K | 0 |
| 2021-04-07 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (right to buy) | −15,383 | 287,227 | ||
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Exercise or conversion | +5,188 | $12.85 | $67K | 876,061 |
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Exercise or conversion | +5,188 | $12.85 | $67K | 9,252,951 |
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −5,188 | 41,500 | ||
| 2021-01-27 | BAKER BROS. ADVISORS LP Director | Exercise or conversion · Non-Qualified Stock Options (right to buy) | −5,188 | 41,500 | ||
| 2021-01-11 | BAKER BROS. ADVISORS LP Director | Purchase · Non-Voting Common Stock | +12,444 | $60.00 | $747K | 509,480 |
| 2021-01-11 | BAKER BROS. ADVISORS LP Director | Purchase · Non-Voting Common Stock | +154,222 | $60.00 | $9.3M | 5,212,371 |
| 2021-01-11 | ORBIMED ADVISORS LLC Director | Purchase · Non-Voting Common Stock | +41,700 | $60.00 | $2.5M | 5,596,886 |
| 2021-01-11 | Bonita David P Director | Purchase · Non-Voting Common Stock | +41,700 | $60.00 | $2.5M | 5,596,886 |
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +329,478 | 350,169 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +2,965,263 | 3,151,483 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +370,552 | 720,721 | ||
| 2020-09-29 | BAKER BROS. ADVISORS LP Director | Conversion | +4,047,634 | 7,199,117 |
Page 15 of 19 · 369 trades